Empowered Funds
SGMT icon

Empowered Funds’s Sagimet Biosciences SGMT Stock Holding History

Empowered Funds’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$328K Buy
+33,237
New +$305K ﹤0.01% 1999

Other funds holding SGMT

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Silverarc Capital Management
Silverarc Capital Management Boston, Massachusetts $854M AUM 179.73% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Affinity Asset Advisors
Affinity Asset Advisors New York $2.46B AUM 196.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Spruce Street Capital
Spruce Street Capital New York $629M AUM 210.46% 1-Year Est. Return
Blue Owl Capital Holdings
Blue Owl Capital Holdings New York $548M AUM 35.34% 1-Year Est. Return

Empowered Funds's SGMT Position: Q3 2026 in Review

Empowered Funds opened a new position in Sagimet Biosciences (SGMT) in Q3 2026: 33,237 shares worth $328K. The stake represents ﹤0.01% of the portfolio and ranks #1999 among its holdings.

92 funds tracked by Wall St. Rank hold SGMT as of Q3 2026.

  • Empowered Funds held 33,237 shares of Sagimet Biosciences worth $328K as of Q3 2026.
  • Sagimet Biosciences was a new Empowered Funds position in Q3 2026.
  • Sagimet Biosciences made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #1999 holding.
  • 92 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.